Events and presentations
Featured presentation
Latest presentations
Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 in GBS
Upcoming events
Full-year Report for January-December 2024
Annual Report 2024
Interim Report for January-March 2025
Presentations
| 2024 | Presentation | Webcast |
|---|---|---|
18 Dec 2024 Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 in GBS | ||
17 Oct 2024 Hansa Biopharma Corporate Presentation October 2024 | ||
17 Oct 2024 Interim Report January-September 2024 presentation | ||
07 Oct 2024 12-month follow up analysis from the NICE-01 trial of HNSA-5487 | ||
18 Jul 2024 Interim report January-June 2024 presentation | ||
18 Jul 2024 Hansa Corporate Presentation July 2024 | ||
11 Jun 2024 ABGSC Digital Autoimmunity, Transplantation, and Inflammation Seminar | ||
27 May 2024 Carnegie Reverse Road Show, Lund | ||
14 May 2024 Capital One Biotech Disruptors | ||
18 Apr 2024 Investor Road Show Presentation Q1 2024 | ||
07 Mar 2024 Life Sciencedagen, Gothenburg | ||
04 Mar 2024 TD Cowen Healthcare Conference, Boston | ||
28 Feb 2024 Økonomisk Ugebrev Investor Presentation | ||
14 Feb 2024 Redeye Theme: Regenerative Medicine/Cell Therapy | ||
02 Feb 2024 Investor Road Show Presentation Year-end Report/Q4 2023 | ||
06 Jan 2024 Investor Road Show Presentation Q4 2023 |